• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMJ Open Respir Res . Associations between respiratory diseases and lung cancer risk: a secondary analysis of the large-scale prospective UK bioban

tetano

Editor, Senior Moderator
BMJ Open Respir Res


. 2026 Apr 3;13(1):e003571.
doi: 10.1136/bmjresp-2025-003571.
Associations between respiratory diseases and lung cancer risk: a secondary analysis of the large-scale prospective UK biobank cohort

Qiu Zhong[SUP] 1 2 [/SUP], Yi Feng[SUP] 3 2 [/SUP], Xiangyuan Zheng[SUP] 3 2 [/SUP], Ying Deng[SUP] 3 2 [/SUP], Juan He[SUP] 3 2 [/SUP], Jianfu Li[SUP] 3 2 [/SUP], Xinyi Wu[SUP] 4 [/SUP], Zixun Wang[SUP] 4 [/SUP], Runchen Wang[SUP] 3 2 [/SUP], Ruixiang Sun[SUP] 4 [/SUP], Xuanzhuang Lu[SUP] 3 2 [/SUP], Jianxing He[SUP] 3 2 [/SUP], Bo Cheng[SUP] 5 [/SUP], Wenhua Liang[SUP] 1 2 [/SUP]


Affiliations
Abstract

Introduction: Respiratory diseases are significant risk factors for lung cancer; however, the association between acute respiratory infections and lung cancer incidence requires further exploration.
Methods: We performed a secondary analysis of the prospective UK Biobank cohort, including participants aged 37-73 years recruited from 22 assessment centres across the UK between 2006 and 2010. Cox proportional hazards models estimated HRs for incident lung cancer according to respiratory disease status, which was defined based on linked hospital inpatient records. Mediation analysis explored potential biomarkers, and Mendelian randomisation assessed causal relationships.
Results: During a mean follow-up of 10.44 years (4 790 738 person-years), 2189 participants developed lung cancer. Among 107 007 individuals with respiratory diseases, 1322 cases occurred (incidence rate 27.6 per 10 000 person-years), compared with 867 cases among 351 876 participants without respiratory diseases (7.9 per 10 000 person-years). Overall, respiratory diseases were associated with increased lung cancer risk (HR 2.97, 95% CI 2.75 to 3.21). Acute respiratory infections, including acute nasopharyngitis (HR 3.41; 95% CI 1.83 to 6.34), influenza (HR 3.90; 95% CI 2.53 to 6.01), viral pneumonia (HR 9.86; 95% CI 6.55 to 14.85) and bacterial pneumonia (HR 6.28; 95% CI 4.40 to 8.96), showed strong associations with lung cancer incidence. In subtype analyses, squamous cell carcinoma exhibited the highest risk elevation (HR 3.65; 95% CI 3.06 to 4.36). Mediation analysis indicated that neutrophil counts partially mediated these associations (proportion mediated up to 8%).
Conclusion: Acute respiratory infections were associated with higher lung cancer incidence, providing hypothesis-generating evidence that may inform future risk stratification research.

Keywords: Bacterial Infection; Lung Cancer; Pulmonary Disease, Chronic Obstructive.

 
Back
Top